Filter
130
Text search:
EMA
European
Medicines
Agency
Featured
Recommendations
16
New Publications
30
Language
Document type
No document type
48
Guidelines
34
Studies & Reports
19
Fact sheets
18
Manuals
6
Situation Updates
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Western and Central Europe
5
Germany
4
West and Central Africa
3
Brazil
2
East and Southern Africa
2
Africa
2
Guinea
1
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Ethiopia
1
Uganda
1
Philippines
1
Nepal
1
Zambia
1
Kenya
1
Cambodia
1
Thailand
1
Indonesia
1
Bangladesh
1
Argentina
1
Ukraine
1
Ecuador
1
Latin America and the Carribbean
1
Paraguay
1
Venezuela
1
Eastern Europe
1
Denmark
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
25
Countries
19
Pharmacy & Technologies
6
Women & Child Health
5
Capacity Building
1
Public Health
1
Key Resources
1
Toolboxes
COVID-19
31
AMR
25
HIV
8
TB
8
Pharmacy
8
Ebola
7
Rapid Response
5
Refugee
3
Planetary Health
3
NTDs
3
Zika
2
Mental Health
2
Disability
1
Natural Hazards
1
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa
...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr
...
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedical engineering resources. This publication is int
...
Accessed: 19.10.2019
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
Orientations provisoires 19 juillet 2021
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of
...
